Products for Research Use Only
RegisterLogin

EGFR-IN-175

CAT: 0804-HY-178009Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-178009Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
EGFR-IN-175 is an orally active and selective EGFRL858R/T790M/C797S inhibitor with an IC50 of 18.94 nM. EGFR-IN-175 can induce cell apoptosis and cause G1 phase arrest. EGFR-IN-175 can downregulate p-EGFR, p-AKT, and p-ERK expression. EGFR-IN-175 can be used for the research of cancer, such as lung cancer[1].
UNSPSC
12352005
Target
Akt; Apoptosis; EGFR; PERK
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; JAK/STAT Signaling; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C1C(C2=CC=CS2)=NC3=CN=C(NC4=CC=C(N5CCC(N6CCN(C)CC6)CC5)C=C4)N=C3N1C7=CN(S(=O)(C8CC8)=O)N=C7OC
Molecular Formula
C33H38N10O4S2
Molecular Weight
702.85
References & Citations
[1]Jiang W, et al. Direct Ser797 Interacted Pteridine-7 (8H) -one Derivatives as Highly Selective and Orally Available EGFRL858R/T790M/C797S Inhibitors. J Med Chem. 2025 Sep 11;68 (17) :18463-18490.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-120221-01SE 175
HY-141609-01IK-175
HY-143408OYYF-175
HY-119113C 175
HY-138443ABF-175
HY-126346-01DL-175
HY-163077Anticancer agent 175
HY-145072-01BSJ-01-175
HY-161831Antitumor agent-175
HY-134850-01QC-01–175

Alternative Products

CatalogName
GTR19273139-01EGFR-IN-175
2382158Ceran Mats 175 x 175
018-85A-Beta 175 polypeptide (159-175) (Human)
018-88A-Beta 175 polypeptide (161-175) (Human)
BA5384-5DL-175
WSA25522-01PBDE 175
453935-01LT 175
ARC0857SNU-175
MBS5780269BW 175
TRC-J211420-100MGJWH-175

Popular Products